Search details
1.
Cost-effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model-based analysis.
Int J Cancer
; 154(6): 1073-1081, 2024 Mar 15.
Article
in English
| MEDLINE | ID: mdl-38088449
2.
Divergent effects of switching from cytology to HPV-based screening in the Nordic countries.
Eur J Public Health
; 34(2): 354-360, 2024 Apr 03.
Article
in English
| MEDLINE | ID: mdl-38261374
3.
Livmorhalsprøvetaking i primærhelsetjenesten.
Tidsskr Nor Laegeforen
; 143(11)2023 08 15.
Article
in Norwegian
| MEDLINE | ID: mdl-37589352
4.
Switching clinic-based cervical cancer screening programs to human papillomavirus self-sampling: A cost-effectiveness analysis of vaccinated and unvaccinated Norwegian women.
Int J Cancer
; 150(3): 491-501, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-34664271
5.
HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
Br J Cancer
; 127(10): 1816-1826, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35995936
6.
Does Women's Screening History Have Any Impact on Mammography Screening Attendance After Tailored Education?: A Systematic Review and Meta-analysis.
Med Care
; 59(10): 893-900, 2021 10 01.
Article
in English
| MEDLINE | ID: mdl-34108408
7.
Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening.
Br J Cancer
; 122(11): 1715-1723, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32242098
8.
Adherence to international recommendations in the governance and organisation of Nordic cervical cancer screening programmes.
Acta Oncol
; 59(11): 1308-1315, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32955963
9.
Psychological effect of cervical cancer screening when changing primary screening method from cytology to high-risk human papilloma virus testing.
Int J Cancer
; 145(1): 29-39, 2019 07 01.
Article
in English
| MEDLINE | ID: mdl-30549273
10.
NordScreen - an interactive tool for presenting cervical cancer screening indicators in the Nordic countries.
Acta Oncol
; 58(9): 1199-1204, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31106635
11.
Barriers to cervical cancer screening faced by immigrants: a registry-based study of 1.4 million women in Norway.
Eur J Public Health
; 27(5): 873-879, 2017 10 01.
Article
in English
| MEDLINE | ID: mdl-28957477
12.
Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
J Clin Microbiol
; 50(6): 1927-35, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22518869
13.
Dynamiske screeningprogrammer.
Tidsskr Nor Laegeforen
; 137(14-15)2017 08 22.
Article
in Norwegian
| MEDLINE | ID: mdl-28828792
14.
[Safe implementation of HPV testing in the Norwegian Cervical Cancer Screening Programme]. / Trygg implementering av HPV-testing i Livmorhalsprogrammet.
Tidsskr Nor Laegeforen
; 137(17)2017 09 19.
Article
in Norwegian
| MEDLINE | ID: mdl-28925234
15.
Impact of the Mobile Game FightHPV on Cervical Cancer Screening Attendance: Retrospective Cohort Study.
JMIR Serious Games
; 10(4): e36197, 2022 Dec 13.
Article
in English
| MEDLINE | ID: mdl-36512401
16.
Randomized Implementation of a Primary Human Papillomavirus Testing-based Cervical Cancer Screening Protocol for Women 34 to 69 Years in Norway.
Cancer Epidemiol Biomarkers Prev
; 31(9): 1812-1822, 2022 09 02.
Article
in English
| MEDLINE | ID: mdl-35793700
17.
Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia.
Gynecol Oncol
; 123(2): 257-62, 2011 Nov.
Article
in English
| MEDLINE | ID: mdl-21839500
18.
Comparison of cytology and human papillomavirus-based primary testing in cervical screening programs in the Nordic countries.
J Med Screen
; 28(4): 464-471, 2021 12.
Article
in English
| MEDLINE | ID: mdl-33563086
19.
HPV genotype distribution according to severity of cervical neoplasia.
Gynecol Oncol
; 118(1): 29-34, 2010 Jul.
Article
in English
| MEDLINE | ID: mdl-20406711
20.
Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia.
J Clin Microbiol
; 47(8): 2458-64, 2009 Aug.
Article
in English
| MEDLINE | ID: mdl-19535524